BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 37398664)

  • 1. Risk and Factors associated with disease manifestations in systemic lupus erythematosus - lupus nephritis (RIFLE-LN): a ten-year risk prediction strategy derived from a cohort of 1652 patients.
    Chan SCW; Wang YF; Yap DYH; Chan TM; Lau YL; Lee PPW; Lai WM; Ying SKY; Tse NKC; Leung AMH; Mok CC; Lee KL; Li TWL; Tsang HHL; Yeung WWY; Ho CTK; Wong RWS; Yang W; Lau CS; Li PH
    Front Immunol; 2023; 14():1200732. PubMed ID: 37398664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for subsequent lupus nephritis in patients with juvenile-onset systemic lupus erythematosus: a retrospective cohort study.
    Hsu TC; Yang YH; Wang LC; Lee JH; Yu HH; Lin YT; Hu YC; Chiang BL
    Pediatr Rheumatol Online J; 2023 Mar; 21(1):28. PubMed ID: 36964531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of Anti-Glomerular Basement Membrane Antibodies in 200 Patients With Systemic Lupus Erythematosus With or Without Lupus Nephritis: Results of the GOODLUPUS Study.
    Bourse Chalvon N; Orquevaux P; Giusti D; Gatouillat G; Tabary T; Tonye Libyh M; Chrusciel J; Drame M; Stockton-Bliard G; Amoura Z; Arnaud L; Lorenz HM; Blaison G; Bonnotte B; Magy-Bertrand N; Revuz S; Voll RE; Hinschberger O; Schwarting A; Pham BN; Martin T; Pennaforte JL; Servettaz A
    Front Immunol; 2020; 11():597863. PubMed ID: 33381119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies Targeting Ficolin-2 in Systemic Lupus Erythematosus Patients With Active Nephritis.
    Colliard S; Jourde-Chiche N; Clavarino G; Sarrot-Reynauld F; Gout E; Deroux A; Fougere M; Bardin N; Bouillet L; Cesbron JY; Thielens NM; Dumestre-Pérard C
    Arthritis Care Res (Hoboken); 2018 Aug; 70(8):1263-1268. PubMed ID: 29045037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis.
    Bastian HM; Roseman JM; McGwin G; Alarcón GS; Friedman AW; Fessler BJ; Baethge BA; Reveille JD;
    Lupus; 2002; 11(3):152-60. PubMed ID: 12004788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity.
    Shang X; Ren L; Sun G; Yu T; Yao Y; Wang L; Liu F; Zhang L; He X; Liu M
    Immun Inflamm Dis; 2021 Jun; 9(2):407-418. PubMed ID: 33470559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantigen microarrays reveal autoantibodies associated with proliferative nephritis and active disease in pediatric systemic lupus erythematosus.
    Haddon DJ; Diep VK; Price JV; Limb C; Utz PJ; Balboni I
    Arthritis Res Ther; 2015 Jun; 17(1):162. PubMed ID: 26081107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of circulating miR-148a and miR-126 with autoantibodies as biomarkers of lupus nephritis in patients with SLE.
    Omidi F; Khoshmirsafa M; Kianmehr N; Faraji F; Delbandi A; Seif F; Shekarabi M
    J Immunoassay Immunochem; 2022 Nov; 43(6):634-647. PubMed ID: 35938736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibody cluster analysis in juvenile lupus nephritis.
    Sherman MA; Gunawardana A; Amirault JP; Moudgil A; Bost JE; Sule S; Srinivasalu H
    Clin Rheumatol; 2022 Aug; 41(8):2375-2381. PubMed ID: 35347489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies.
    Pradhan VD; Badakere SS; Bichile LS; Almeida AF
    J Assoc Physicians India; 2004 Jul; 52():533-7. PubMed ID: 15645975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis.
    Alba P; Bento L; Cuadrado MJ; Karim Y; Tungekar MF; Abbs I; Khamashta MA; D'Cruz D; Hughes GR
    Ann Rheum Dis; 2003 Jun; 62(6):556-60. PubMed ID: 12759294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and antinuclear antibodies profile among adults with systemic lupus erythematosus and lupus nephritis: a cross-sectional study.
    Ahmed N; Shigidi M; Al Agib AN; Abdelrahman H; Taha E
    Pan Afr Med J; 2017; 27():114. PubMed ID: 28819535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between immunoglobulin G N-glycosylation and lupus nephritis in female patients with systemic lupus erythematosus: a case-control study.
    Lu X; Wang L; Wang M; Li Y; Zhao Q; Shi Y; Zhang Y; Wang Y; Wang W; Ji L; Hou H; Li D
    Front Immunol; 2023; 14():1257906. PubMed ID: 37809087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early discoid lupus erythematosus protects against renal disease in patients with systemic lupus erythematosus: longitudinal data from a large Latin American cohort.
    Pons-Estel GJ; Aspey LD; Bao G; Pons-Estel BA; Wojdyla D; Saurit V; Alvarellos A; Caeiro F; Haye Salinas MJ; Sato EI; Soriano ER; Costallat LT; Neira O; Iglesias-Gamarra A; Reyes-Llerena G; Cardiel MH; Acevedo-Vásquez EM; Chacón-Díaz R; Drenkard C
    Lupus; 2017 Jan; 26(1):73-83. PubMed ID: 27230554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibody-based subgroups and longitudinal seroconversion in juvenile-onset systemic lupus erythematosus.
    Bao S; Huang H; Jin Y; Ding F; Yang Z; Xu X; Liu C; Lu J; Jin Y
    Lupus Sci Med; 2023 Apr; 10(1):. PubMed ID: 37012058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide DNA methylation analysis implicates enrichment of interferon pathway in African American patients with Systemic Lupus Erythematosus and European Americans with lupus nephritis.
    Allen PC; Roberts K; Rubio JE; Tiwari HK; Absher DM; Cooper SJ; Myers RM; Brown EE
    J Autoimmun; 2023 Sep; 139():103089. PubMed ID: 37506491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polygenic Risk Score Predicts Earlier-Onset Adult Systemic Lupus Erythematosus and First-Year Renal Diseases in a Taiwanese Cohort.
    Chen YJ; Hsiao TH; Lin YC; Jeng WJ; Mao CL; Wei CY; Hsieh YC; Huang CJ; Pan MH; Chen IC; Lin CH; Chen YM; Yang HI
    RMD Open; 2024 Apr; 10(2):. PubMed ID: 38637112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of discordance between anti-dsDNA antibodies by multiplex flow immunoassay and
    Zaminski D; Saxena A; Izmirly P; Buyon JP; Belmont HM
    Lupus Sci Med; 2023 Nov; 10(2):. PubMed ID: 37963669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the relative impact of lupus nephritis on mortality in a population-based systemic lupus erythematosus cohort.
    Reppe Moe SE; Molberg Ø; Strøm EH; Lerang K
    Lupus; 2019 Jun; 28(7):818-825. PubMed ID: 31072277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The outcome of patients with renal involvement in pediatric-onset systemic lupus erythematosus--a 20-year experience in Asia.
    Lee PY; Yeh KW; Yao TC; Lee WI; Lin YJ; Huang JL
    Lupus; 2013 Dec; 22(14):1534-40. PubMed ID: 23966304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.